Stemtrix Corp.

has developed an antibacterial drug that is an alternative to antibiotics.

The drug is designed to prevent and treat intestinal and other inflammatory infections of bacterial nature in farm animals, including poultry.

The drug does not include antibiotics

The drug is a natural component of feed, which is part of the diet of farm animals and birds, used in medicine and food industry.

The use of the drug does not exclude the use of other medicines for animals.

Stemtrix® belongs to prebiotic drugs. The active substance, which is part of the drug, has a wide range of antibacterial actions against most grampositive and gram-negative bacteria, including: Staphylococcus aureus, Streptococcus agalactiae, Streptococcus disagalactiae, Streptococcus uberis, Klebsiella spp, Archaebacterium, E. coli, Ps. aeruginosa.


The drug allows to suppress virulence, pathogenicity of pathogenic bacteria, without resorting to the principle of direct destruction of the bacterium.


The active substances of the drug are natural regulators of metabolic processes in the bacterial cell and as a result the bacterial cell does not have genetically determined mechanisms of resistance to their action.


The drug also includes substances that modulate the immune response to the introduction of the pathogen bacterium.

This leads to the rapid sanitization of the infection and the purchase of an inflammatory reaction in its hearth.